RB1 and large cell neuroendocrine carcinoma: reported patients with LCNEC tumors that carry a wild-type RB1 gene or express the RB1 protein do better with NSCLC type chemotherapy (platinum-gemcitabine or paclitaxel) than with SCLC type chemotherapy (platinum, etoposide).